The new study, published in Cell, solves the mystery of what drives the genetic rearrangements that are responsible for the aggressive development and evolution of osteosarcoma tumors. The researchers ...

Chimeric antigen receptor (CAR) T–cell immunotherapy re-engineers a patient's immune cells to target cancer cells. While successful in some types of leukemia, the approach has yet to realize its ...

Researchers published a new study, “Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution,” in Cell that they say solves the mystery of what drives the genomic ...

Large-scale analysis of patient cohorts reveals a novel mechanism driving osteosarcoma, an aggressive paediatric bone cancer. The researchers show that this mechanism occurs in approximately 50% of ...

Lab tests show that bioactive glasses combined with gallium oxide have a 99% success rate in eliminating bone cancer cells and can even regenerate diseased bone. The corresponding study was published ...

Scientists have demonstrated a new potential treatment for bone cancer. A bioactive glass laced with a toxic metal was able to kill up to 99% of the cancer without harming healthy cells, and could ...

Bioactive glasses, doped with gallium developed to create a potential treatment for bone cancer Lab tests have a 99 percent success rate of killing cancerous cells Method could also regenerate ...

In a medical breakthrough, scientists have discovered a new potential treatment for bone cancer. The new treatment includes bioactive glasses, a filling material that can bond to tissue and improve ...

FDA confirmed that data from single-arm studies in rare diseases, such as in ultra-rare deadly pediatric cancer osteosarcoma, could support a Biologics Licensing Application (BLA) under Accelerated ...